BSGM Overview

Partnership Announcement: Streamex and Simplify Asset Management have signed a letter of intent to explore a strategic partnership aimed at integrating Streamex's tokenized yield-bearing gold into Simplify's ETF structures, enhancing access to innovative financial products.

Product Development Goals: The collaboration intends to develop and distribute tokenized exchange-traded products (ETPs) and ETFs that provide investors with regulated, liquid, and yield-generating exposure to gold and other commodities, subject to regulatory approval.

Modular Medical Inc. (MODD): The stock surged 30.68% to $0.9150 after announcing the completion of a clinical study for its MODD1 insulin pump and plans to submit its Pivot pump to the FDA in October 2025, alongside significant insider buying activity.

Galectin Therapeutics Inc. (GALT): The stock rose over 14% to $6.78, continuing a year-to-date gain of over 360%, with CEO Joel Lewis indicating ongoing analysis of biomarkers for their lead candidate, belapectin, which targets MASH cirrhosis and portal hypertension.

Exicure Inc. (XCUR): Shares increased 11.11% to $4.00 despite no new announcements, following a wider net loss reported for Q2 2025, as the company pivots its focus to new clinical directions after acquiring GPCR USA.

BioSig Technologies Inc. (BSGM): The stock gained 37.08% to $6.10, with an additional rise after announcing its rebranding to Streamex Corp. and a shift in focus towards real-world asset tokenization, including a partnership to develop tokenized gold products.

Company Name Change: BioSig Technologies, Inc. will change its name to Streamex Corp. and its trading symbol to "STEX" effective September 12, 2025, with all stock trading and filings reported under the new symbol.

Streamex Overview: Streamex is a tokenization company focused on Real World Assets (RWA), particularly in the gold and commodities market, and operates as a wholly owned subsidiary of BioSig Technologies, Inc.

BioSig Technologies Background: BioSig is a medical device technology company known for its PURE EP™ Platform, which aids electrophysiologists in treating cardiovascular arrhythmias.

Forward-Looking Statements: The press release includes forward-looking statements that are subject to risks and uncertainties, emphasizing that actual results may differ from anticipated outcomes based on various factors.

Partnership Announcement: Monetary Metals has partnered with Streamex to provide yield on physical gold bullion, leveraging over $1 billion in lease capacity and exclusive rights to utilize Streamex's tokenized gold.

Innovative Financial Solutions: The collaboration aims to create yield-bearing digital assets by financing real-world gold businesses, enhancing gold's role as both a store of value and a source of income through blockchain tokenization.

BioSig Technologies Public Offering: BioSig Technologies, Inc. has successfully closed an underwritten public offering of 3,852,149 shares at $3.90 per share, raising approximately $15 million to fund gold bullion purchases and general corporate purposes following its merger with Streamex Exchange Corporation.

Company's Future Plans: The CEO, Henry McPhie, emphasized the company's strategy to enhance shareholder value and establish a leading position in the gold bullion market through the integration of advanced technology and infrastructure provided by Streamex.

Public Offering Announcement: BioSig Technologies has priced an underwritten public offering of 3,852,149 shares at $3.90 per share, aiming to raise approximately $15 million, with the offering expected to close around August 15.

Use of Proceeds: The company plans to utilize the net proceeds for purchasing gold bullion in accordance with its investment policy, as well as for working capital and general corporate purposes.